Compare NIM & IXHL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
| Metric | NIM | IXHL |
|---|---|---|
| Founded | 1992 | 2001 |
| Country | United States | Australia |
| Employees | N/A | N/A |
| Industry | Trusts Except Educational Religious and Charitable | |
| Sector | Finance | |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 116.1M | 134.7M |
| IPO Year | N/A | N/A |
| Metric | NIM | IXHL |
|---|---|---|
| Price | $9.48 | $0.29 |
| Analyst Decision | | |
| Analyst Count | 0 | 0 |
| Target Price | N/A | N/A |
| AVG Volume (30 Days) | 35.4K | ★ 7.0M |
| Earning Date | 01-01-0001 | 02-13-2026 |
| Dividend Yield | ★ 3.46% | N/A |
| EPS Growth | N/A | N/A |
| EPS | ★ N/A | N/A |
| Revenue | N/A | ★ $12,000.00 |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | N/A | N/A |
| Revenue Growth | ★ N/A | N/A |
| 52 Week Low | $8.28 | $0.08 |
| 52 Week High | $9.74 | $2.25 |
| Indicator | NIM | IXHL |
|---|---|---|
| Relative Strength Index (RSI) | 61.85 | 26.52 |
| Support Level | $9.27 | $0.30 |
| Resistance Level | $9.44 | $0.34 |
| Average True Range (ATR) | 0.09 | 0.02 |
| MACD | 0.01 | -0.01 |
| Stochastic Oscillator | 85.65 | 6.57 |
Nuveen Select Maturities Municipal Fund is a diversified closed-end management investment company. Its primary investment objective is to provide current income exempt from regular federal income tax, consistent with the preservation of capital. Its secondary investment objective is to enhance portfolio value relative to the municipal bond market through investments in tax-exempt municipal obligations that are underrated or undervalued, or that represent municipal market sectors that are undervalued.
Incannex Healthcare Inc is a clinical stage pharmaceutical company developing medical cannabis products for the treatment of Obstructive Sleep Apnea (OSA), Traumatic Brain Injury (TBI)/Concussion, Rheumatoid Arthritis, Inflammatory Bowel Disease, and Inflammatory Lung Conditions. The company has an Australian license to import, export, and distribute medicinal cannabis products and has launched a line of cannabinoid products. The Company operates and manages its business as one reportable and operating segment, which is the Research and Development of the use of psychedelic medicine and therapies.